CV
CVNZF.US Comvita Limited
- Market cap
- USD 54.0M
- P/E
- -
- P/B
- 0.88x
- ROE
- 8.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is CVNZF.US undervalued?
Graham numberThe Graham number of Comvita Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Comvita Limited fundamental analysis
No fundamental analysis for Comvita Limited yet.
Comvita Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Comvita Limited
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution of Manuka honey, bee products, and olive leaf products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, and Africa. The company offers bee propolis, olive leaf extract and cardio health products, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in…
Full company profileComvita Limited financial statements
Comvita Limited annual financial statements (NZD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 156M | 177M | 169M | 195M | 192M | 209M | 234M | 204M | 192M | 212M |
| Gross Profit | 61.3M | 69.3M | 60.0M | 92.3M | 103M | 126M | 136M | 112M | 82.7M | 114M |
| Operating Income | 25.0K | 6.34M | -11.5M | 690K | 12.2M | 20.1M | 23.9M | -7.34M | -29.0M | 12.9M |
| EBITDA | 6.85M | 12.5M | -18.0M | 6.83M | 22.6M | 31.1M | 27.3M | -59.8M | -14.8M | 21.9M |
| Net Income | 9.82M | 8.21M | -27.7M | -9.70M | 9.48M | 12.8M | 11.1M | -77.4M | -105M | 7.70M |
| EPS | 0.22 | 0.17 | -0.56 | -0.19 | 0.14 | 0.18 | 0.16 | -1.10 | -1.49 | 0.10 |
| Balance Sheet | ||||||||||
| Total Assets | 257M | 319M | 314M | 287M | 288M | 334M | 359M | 308M | 173M | 164M |
| Total Liabilities | 92.8M | 129M | 141M | 75.6M | 65.8M | 106M | 119M | 147M | 118M | 67.7M |
| Shareholders' Equity | 164M | 190M | 173M | 212M | 222M | 228M | 239M | 161M | 54.9M | 96.3M |
| Cash & Short-term Investments | 6.90M | 4.95M | 10.3M | 16.7M | 16.3M | 17.8M | 11.6M | 8.16M | 9.00M | 12.9M |
| Total Debt | 66.5M | 96.7M | 99.3M | 43.8M | 34.4M | 56.1M | 80.3M | 109M | 91.7M | 30.4M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -10.7M | -21.9M | 21.9M | 39.3M | 25.2M | 2.83M | 8.08M | 5.33M | 34.1M | 34.9M |
| Capital Expenditure | 3.87M | 5.53M | 16.7M | 5.70M | 11.0M | 9.45M | 20.4M | 9.70M | 3.25M | 1.26M |
| Free Cash Flow | -14.6M | -27.4M | 5.20M | 33.6M | 14.2M | -9.45M | -20.4M | -4.37M | 30.9M | 33.7M |
| Ratios | ||||||||||
| ROE | 6.0% | 4.3% | -16.0% | -4.6% | 4.3% | 5.6% | 4.6% | -48.2% | -190.8% | 8.0% |
| ROA | 3.8% | 2.6% | -8.8% | -3.4% | 3.3% | 3.8% | 3.1% | -25.1% | -60.4% | 4.7% |
| Net Profit Margin | 6.3% | 4.6% | -16.4% | -5.0% | 4.9% | 6.1% | 4.7% | -37.9% | -54.4% | 3.6% |
| Debt to Equity | 0.41x | 0.51x | 0.57x | 0.21x | 0.16x | 0.25x | 0.34x | 0.68x | 1.67x | 0.32x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Comvita Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Apr 3, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | NZD 2.90M | 0.04 | - |
| 2023 | USD 3.96M | 0.06 | 35.8% |
| 2022 | USD 4.70M | 0.07 | 36.8% |
| 2021 | USD 12.6M | 0.18 | 133.2% |
| 2020 | USD 20.0M | 0.39 | - |
| 2019 | USD 918K | 0.02 | - |
| 2018 | USD 1.85M | 0.04 | 22.5% |
| 2017 | USD 1.71M | 0.04 | 17.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1071:1000 on Jul 13, 2020.
Who owns Comvita Limited
- Insiders 61.16%
- Institutions 0.00%
- Public & others 38.84%
- Shares outstanding 130M
- Free float 66.6M
Comvita Limited company profile
- Company name
- Comvita Limited
- Ticker
- CVNZF.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 385
- Fiscal year end
- June
- Address
- 23 Wilson Road South, Te Puke, New Zealand, 3153
- Phone
- 64 7 533 1426
- Website
- comvita.co.nz
About Comvita Limited
Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution of Manuka honey, bee products, and olive leaf products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, and Africa. The company offers bee propolis, olive leaf extract and cardio health products, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also engages in the apiary ownership and forest management activities. The company sells its products online through its website. Comvita Limited was incorporated in 1974 and is based in Te Puke, New Zealand.
Comvita Limited management
10- Mr. Karl GradonChief Executive Officer
- Ms. Mandy Tomkins-DanceyChief Financial Officer
- Mr. Ben DuncanChief Operating Officer
- Dr. Jackie EvansChief Science Officer
- Jodie WilliamsInvestor Relations
- Ms. Andrea WilkinsChief Marketing Officer
- Ms. Nikki LeskeChief People & Culture Officer
- Ms. Erin SwansonHead of Sustainability & Strategic Projects
- Ms. Emma BlottChief Commercial Officer
- Sarah KenyonHead of Quality and Regulatory Affairs